In the multivariable analysis (Model 1), the positivity of the D-marker panel remained an independent risk factor for cancer progression after adjusting for cancer differentiation, KRAS mutation, and BRAF mutation, and the adjusted hazard ratio (HR) (95% CI) was 1.52 (1.09 to 2.11). Here, KRAS is linked to cancer.